Founded in 2019, Integration operates Medistream, a digital community that counts over 23,700 members—about 85% of all licensed Korean traditional medicine doctors. Building on this captive user base, the company has expanded into clinic-specific commerce for medical devices and consumables, proprietary traditional medicine brands such as Su, Lin Diet, and Acurex, and cloud-based EMR/CRM software. These services aim to streamline non-clinical workflows so practitioners can focus on patient care while boosting revenue. The domestic traditional medicine clinic market is estimated at ₩8 trn with 96 m annual patient visits, giving Integration a large addressable market. The firm’s branded product line generated ₩45.4 bn in revenue last year, growing 73% year-on-year. Future plans include elevating clinic infrastructure across Korea and taking its consumer health brands to global markets, positioning the company as a leading “K-Hanbang” (Korean traditional medicine) champion.

Total raised

$36M

Funding rounds

2

Latest round

Series C

Latest activity

Dec 2025